Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

$2.05
0.35 (20.59%)
OTLK
NASDAQ Capital Market
USD, US
Biotechnology
Product SegmentationGeographic Segmentation

Revenue Segmentation by product